• Home Blog Tag Spinal muscular atrophy treatment

Spinal Muscular Atrophy treatment

Feb 28, 2023

SpringWorks’s Desmoid Tumors Therapeutic, Nirogacestat; Orphan Drug Designation to AskBio’s AB-1003; Mitsubishi Tanabe’s Phase 3 Trial of RADICAVA ORS in ALS; EU Orphan Drug Designation to Sage Therapeutics’s SAGE-718; FDA Fast Track Status to Biohaven’s Taldefgrobep Alfa

May 27, 2019

Meet the World’s most expensive drug: Zolgensma

May 06, 2019

Spinal Muscular Atrophy Market

Apr 29, 2019

Spinal Muscular Atrophy: Current and Emerging Therapies

Apr 26, 2019

Spinal Muscular Atrophy Market is expected to augment at a CAGR of 10.42%

Newsletter/Whitepaper